提醒成功
            
            搜索
        | 产品规范 | |
|---|---|
| Type | In Vivo - Reseach Grade Antibody | 
| Host | CHO cells | 
| catalog# | B00064 | 
| Application | Flow cytometry, animal model study | 
| Aliases | Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 | 
| Size/Concentration | 1mg/5mg/20mg | 
| Isotype | Human IgG1 kappa | 
| Storage | Store at 4°C 1 month, store at -20°C to -70°C 12 month. protected from prolonged exposure to light. Avoid freeze/thaw cycles. | 
| Species Reactivity | Human | 
| Immunogen | Human CEACAM5 | 
| Formulation | PBS, pH 7.4 | 
Description | 
									
|---|
What is tusamitamab biosimilar research grade? Tusamitamab is a humanized IgG1-kappa monoclonal antibody targeting carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5) which is overexpressed in tumors including non-small cell lung cancer (NSCLC) and pancreatic ductal adenocarcinoma (PDAC), and is an attractive target for therapies based on CAR-T cell or/and ADCs. Tusamitamab ravtansine (SAR408701) is an antibody-drug conjugate (ADC) combining a humanized monoclonal antibody and a potent cytotoxic maytansinoid derivative (DM4) inhibiting microtubule assembly. Tusamitamab biosimilar uses the same protein sequences as the therapeutic antibody tusamitamab. | 
									
Tusamitamab Biosimilar, Human CEACAM5 Monoclonal Antibody  B00064
							规格:
- 1mg
 - 5mg
 - 20mg
 
数量:
-
											
											+
										说明书:
										
										
										¥2275
- 
										
										咨询
									 - 
										
										收藏
									 
        
    
                
        
                    
        
        
        
        
        
                
                
 微信/QQ登录


 首页